The Korea Times close
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
Business
  • Tech
  • Bio
  • Companies
Finance
  • Companies
  • Economy
  • Markets
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
Entertainment
& Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
Sports
World
  • SCMP
  • Asia
Video
  • Culture
  • People
  • News
Photos
  • Photo News
  • Darkroom
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
Business
Bio
  • Tech
  • Bio
  • Companies
Fri, May 20, 2022 | 09:26
HLB gets positive Phase 3 data with liver cancer treatment
HLB gets positive Phase 3 data with liver cancer treatment
HLB has taken a step closer to the global commercialization of its anticancer treatment Rivoceranib as it secured statistical significance in Phase 3 global clinical trials of the drug, according to the local biotech company, Sunday.
Baek Byung-yeul | 2022-05-15 16:23
Lotte seeks to acquire US CMO plant to enter bioindustry
Lotte seeks to acquire US CMO plant to enter bioindustry
Lotte Group is in the process of acquiring a bioindustry contract manufacturing (CMO) plant in the U.S., according to the investment banking industry, Thursday. The move comes after the conglomerate declared the bioindustry as its new growth engine. CMOs specialize in producing biopharmaceuticals developed by other companies.
Kim Hyun-bin | 2022-05-05 14:46
CHA Biotech's US subsidiary opens CDMO plant in Texas
CHA Biotech's US subsidiary opens CDMO plant in Texas
Matica Biotechnology, a U.S. affiliate of CHA Biotech, has opened a cell and gene therapy manufacturing facility in College Station, Texas, according to the cell therapeutics and stem cell developer affiliate of CHA Medical & Bio Group, Wednesday.
Lee Kyung-min | 2022-05-04 15:53
Osstem Implant posts record profits for Q1
Osstem Implant posts record profits for Q1
Osstem Implant posted a record operating profit for the first quarter, the dental equipment manufacturer said Friday.
Baek Byung-yeul | 2022-04-29 16:30
HLB posts earnings surprise in Q1
HLB posts earnings surprise in Q1
Local biotech company HLB posted sales and operating profit records for the first quarter. The company announced on April 25 that its quarterly sales rose a whopping 1,052 percent from the same period in 2021 to 63.4 billion won ($50.8 million). Its operating profit also came to 18.8 billion won to turn into a surplus. Both sales and operating profit figures were the highest ...
Baek Byung-yeul | 2022-04-26 15:12
Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine
Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine
President Moon Jae-in praised a successful Phase 3 trial of the nation's first homegrown COVID-19 vaccine, developed by SK Bioscience, Tuesday.
2022-04-26 15:09
Yoon to visit headquarters of homegrown COVID-19 vaccine
Yoon to visit headquarters of homegrown COVID-19 vaccine
President-elect Yoon Suk-yeol will visit homegrown vaccine producer SK Bioscience on Monday and emphasize vaccine sovereignty amid the country's fight against the novel coronavirus, his spokesperson said.
2022-04-25 10:58
SD Biosensor, Korean COVID-19 test kit maker, to buy Italian firm for 61.9 billion won
SD Biosensor, Korean COVID-19 test kit maker, to buy Italian firm for 61.9 billion won
SD Biosensor, a Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won ($49.8 million) in an effort to tap deeper into the European market.
2022-04-22 15:10
SK bioscience to develop antiviral nasal spray
SK bioscience to develop antiviral nasal spray
SK bioscience, a biotech affiliate of SK Group, said Wednesday that it will develop a spray-type antiviral drug, with research funds provided by the Bill & Melinda Gates Foundation, a private foundation.
Lee Kyung-min | 2022-04-14 09:03
Medytox takes patent fight with Hugel to USITC
Medytox takes patent fight with Hugel to USITC
Another patent war among domestic botulinum toxin (BTX or Botox) makers has broken out after Medytox accused its local competitor, Hugel, of stealing its BTX strains, filing a lawsuit with the United States International Trade Commission (USITC), according to company officials, Tuesday.
Baek Byung-yeul | 2022-04-05 16:47
 1 23
Top 10 Stories
  • People in North Korea trapped in famine and pandemic [PHOTOS]
  • Korea to resume issuing short-term travel visas, e-visas next month
  • Why doctors oppose Nursing Act legislation
  • KBO commissioner proposes holding season openers, regular games in US in meeting with MLB official
  • Luna fiasco escalates into class action by victims
  • Consumers alarmed by high sodium, saturated fat in meal-kits
  • Black Eagles seek to show ROK Air Force's prowess in England
  • Huge fire erupts at S-Oil's Ulsan factory
  • US denial of Biden-Moon meeting triggers speculation
  • Small Seoul temple becomes beacon for religious harmony
DARKROOM
  • People in North Korea trapped in famine and pandemic [PHOTOS]

    People in North Korea trapped in famine and pandemic [PHOTOS]

  • 2022 Pulitzer Prize: Bearing witness to history

    2022 Pulitzer Prize: Bearing witness to history

  • Worsening drought puts millions at risk

    Worsening drought puts millions at risk

  • Our children deserve the best

    Our children deserve the best

  • End of mask mandates

    End of mask mandates

The Korea Times
CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Location
  • Media Kit
  • Contact Us
  • Products & Service
  • Subscribe
  • E-paper
  • Mobile Service
  • RSS Service
  • Content Sales
  • Policy
  • Privacy Statement
  • Terms of Service
  • 고충처리인
  • Youth Protection Policy
  • Code of Ethics
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group